Literature DB >> 24719956

Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer.

Sajjad Karim, Zeenat Mirza, Muhammad Imran Naseer, Mohammed Hussain Al-Qahtani, Arif Ali.   

Abstract

BACKGROUND/AIMS: The present study was aimed to investigate the correlation between selected clinicopathological characteristics and p53 protein overexpression, in Indian gastric cancer patients.
METHODOLOGY: Here, we studied specimens from 103 patients with gastric carcinomas and cases were categorized by AJCC-TNM classification. The p53 expression was analyzed in all the specimens by immunohistochemistry (IHC) and was correlated with the clinicopathological characteristics of the patients as well as etiological factors for gastric cancer. The cases were considered p53 overexpressed if more than 25% of the tumor cells were found to be expressing this protein.
RESULTS: We found significant association of p53 overexpression with the gender (p = 0.004) and histology grades (p = 0.001). However, p53 overexpression was not found to be significantly associated with other clinicopathological characteristics like age, cell differentiation, stage and location and various etiological factors.
CONCLUSIONS: Our observation showed that IHC-based detection of altered expression of p53 protein in gastric carcinomas may play an important role for diagnosing the progression of gastric carcinoma, even in the early stages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24719956

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

Review 1.  Molecular alterations in gastric cancer with special reference to the early-onset subtype.

Authors:  Małgorzata Skierucha; Anya Na Milne; G Johan A Offerhaus; Wojciech P Polkowski; Ryszard Maciejewski; Robert Sitarz
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

2.  Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors.

Authors:  Yun-feng Qi; Yan-xin Huang; Yan Dong; Li-hua Zheng; Yong-li Bao; Lu-guo Sun; Yin Wu; Chun-lei Yu; Hong-yu Jiang; Yu-xin Li
Journal:  Comput Math Methods Med       Date:  2014-10-13       Impact factor: 2.238

3.  IL-6 and miR-1271 expression levels in elderly and young gastric cancer patients and correlation analysis with prognosis.

Authors:  Shixiong Liu; Yun Zhou; Li Zhao; Jing Wang; Rui Ji; Yiqing Wang; Jiyin Wu; Xiang Yan
Journal:  Oncol Lett       Date:  2019-04-09       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.